Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
1.090
0.00 (0.01%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Eyenovia Employees
As of December 31, 2024, Eyenovia had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees decreased by 43 or -75.44% compared to the previous year.
Employees
14
Change (1Y)
-43
Growth (1Y)
-75.44%
Revenue / Employee
$4,095
Profits / Employee
-$3,558,460
Market Cap
3.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
EYEN News
- 14 days ago - Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - GlobeNewsWire
- 5 weeks ago - Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewsWire
- 2 months ago - Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewsWire
- 2 months ago - Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives - GlobeNewsWire
- 2 months ago - Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - GlobeNewsWire
- 3 months ago - Eyenovia Announces 1-for-80 Reverse Stock Split - GlobeNewsWire
- 3 months ago - Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - GlobeNewsWire
- 3 months ago - Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - GlobeNewsWire